PSEN1 and Alzheimer disease: Further, as reported previously (Taniuchi et al., 2007), the number of BrdU-positive proliferating cells in APP/PS1 mouse brains were remarkably decreased by 40% (Fig.2E,G,I), indicating deficits in NPC proliferation in these AD transgenic mice.